{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T05:46:50Z","timestamp":1769060810600,"version":"3.49.0"},"publisher-location":"New York, NY","reference-count":26,"publisher":"Springer New York","isbn-type":[{"value":"9781493987955","type":"print"},{"value":"9781493987962","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-8796-2_6","type":"book-chapter","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T11:59:43Z","timestamp":1549454383000},"page":"61-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Preclinical Breast Cancer Models to Investigate Metabolic Priming by Methionine Restriction"],"prefix":"10.1007","author":[{"given":"Elena","family":"Strekalova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry","family":"Malin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harisha","family":"Rajanala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent L.","family":"Cryns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"6_CR1","first-page":"2479","volume":"53","author":"HY Guo","year":"1993","unstructured":"Guo HY, Herrera H, Groce A, Hoffman RM (1993) Expression of the biochemical defect of methionine dependence in fresh patient tumors in primary histoculture. Cancer Res 53:2479\u20132483","journal-title":"Cancer Res"},{"key":"6_CR2","first-page":"634","volume":"40","author":"W Kreis","year":"1980","unstructured":"Kreis W, Baker A, Ryan V, Bertasso A (1980) Effect of nutritional and enzymatic methionine deprivation upon human normal and malignant cells in tissue culture. Cancer Res 40:634\u2013641","journal-title":"Cancer Res"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0304-3835(01)00852-7","volume":"179","author":"S Lu","year":"2002","unstructured":"Lu S, Hoestje SM, Choo EM, Epner DE (2002) Methionine restriction induces apoptosis of prostate cancer cells via the c-Jun N-terminal kinase-mediated signaling pathway. Cancer Lett 179:51\u201358","journal-title":"Cancer Lett"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/0006-291X(83)91218-4","volume":"117","author":"JO Mecham","year":"1983","unstructured":"Mecham JO, Rowitch D, Wallace CD, Stern PH, Hoffman RM (1983) The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun 117:429\u2013434","journal-title":"Biochem Biophys Res Commun"},{"key":"6_CR5","first-page":"717","volume":"15","author":"Y Hoshiya","year":"1995","unstructured":"Hoshiya Y, Guo H, Kubota T, Inada T, Asanuma F, Yamada Y et al (1995) Human tumors are methionine dependent in vivo. Anticancer Res 15:717\u2013718","journal-title":"Anticancer Res"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0003-9861(59)90224-3","volume":"81","author":"T Sugimura","year":"1959","unstructured":"Sugimura T, Birnbaum SM, Winitz M, Greenstein JP (1959) Quantitative nutritional studies with water-soluble, chemically defined diets. VII. Nitrogen balance in normal and tumor-bearing rats following forced feeding. Arch Biochem Biophys 81:439\u2013447","journal-title":"Arch Biochem Biophys"},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/01635580701525877","volume":"60","author":"X Durando","year":"2008","unstructured":"Durando X, Thivat E, Farges MC, Cellarier E, D'Incan M, Demidem A et al (2008) Optimal methionine-free diet duration for nitrourea treatment: a phase I clinical trial. Nutr Cancer 60:23\u201330","journal-title":"Nutr Cancer"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1207\/S15327914NC422_2","volume":"42","author":"DE Epner","year":"2002","unstructured":"Epner DE, Morrow S, Wilcox M, Houghton JL (2002) Nutrient intake and nutritional indexes in adults with metastatic cancer on a phase I clinical trial of dietary methionine restriction. Nutr Cancer 42:158\u2013166","journal-title":"Nutr Cancer"},{"key":"6_CR9","first-page":"5235","volume":"29","author":"E Thivat","year":"2009","unstructured":"Thivat E, Farges MC, Bacin F, D'Incan M, Mouret-Reynier MA, Cellarier E et al (2009) Phase II trial of the association of a methionine-free diet with cystemustine therapy in melanoma and glioma. Anticancer Res 29:5235\u20135240","journal-title":"Anticancer Res"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1158\/1078-0432.CCR-14-2792","volume":"21","author":"E Strekalova","year":"2015","unstructured":"Strekalova E, Malin D, Good DM, Cryns VL (2015) Methionine deprivation induces a targetable vulnerability in triple-negative breast cancer cells by enhancing TRAIL receptor-2 expression. Clin Cancer Res 21:2780\u20132791","journal-title":"Clin Cancer Res"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/B978-0-12-417158-9.00005-4","volume":"544","author":"P Nair","year":"2014","unstructured":"Nair P, Lu M, Petersen S, Ashkenazi A (2014) Apoptosis initiation through the cell-extrinsic pathway. Methods Enzymol 544:99\u2013128","journal-title":"Methods Enzymol"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1158\/1078-0432.CCR-09-1267","volume":"16","author":"DR Camidge","year":"2010","unstructured":"Camidge DR, Herbst RS, Gordon MS, Eckhardt SG, Kurzrock R, Durbin B et al (2010) A phase I safety and pharmacokinetic study of the death receptor 5 agonistic antibody PRO95780 in patients with advanced malignancies. Clin Cancer Res 16:1256\u20131263","journal-title":"Clin Cancer Res"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1200\/JCO.2009.25.1991","volume":"28","author":"RS Herbst","year":"2010","unstructured":"Herbst RS, Eckhardt SG, Kurzrock R, Ebbinghaus S, O'Dwyer PJ, Gordon MS et al (2010) Phase I dose-escalation study of recombinant human Apo2L\/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer. J Clin Oncol 28:2839\u20132846","journal-title":"J Clin Oncol"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.1158\/1078-0432.CCR-10-0631","volume":"16","author":"RS Herbst","year":"2010","unstructured":"Herbst RS, Kurzrock R, Hong DS, Valdivieso M, Hsu CP, Goyal L et al (2010) A first-in-human study of conatumumab in adult patients with advanced solid tumors. Clin Cancer Res 16:5883\u20135891","journal-title":"Clin Cancer Res"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/sj.bjc.6605507","volume":"102","author":"T Trarbach","year":"2010","unstructured":"Trarbach T, Moehler M, Heinemann V, Kohne CH, Przyborek M, Schulz C et al (2010) Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer. Br J Cancer 102:506\u2013512","journal-title":"Br J Cancer"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1210\/me.2010-0164","volume":"25","author":"DJ Toft","year":"2011","unstructured":"Toft DJ, Cryns VL (2011) Minireview: basal-like breast cancer: from molecular profiles to targeted therapies. Mol Endocrinol 25:199\u2013211","journal-title":"Mol Endocrinol"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1023\/A:1025837631179","volume":"20","author":"DC Lev","year":"2003","unstructured":"Lev DC, Kiriakova G, Price JE (2003) Selection of more aggressive variants of the gI101A human breast cancer cell line: a model for analyzing the metastatic phenotype of breast cancer. Clin Exp Metastasis 20:515\u2013523","journal-title":"Clin Exp Metastasis"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1172\/JCI25888","volume":"116","author":"JV Moyano","year":"2006","unstructured":"Moyano JV, Evans JR, Chen F, Lu M, Werner ME, Yehiely F et al (2006) \u03b1B-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J Clin Invest 116:261\u2013270","journal-title":"J Clin Invest"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"5005","DOI":"10.1158\/1078-0432.CCR-11-0099","volume":"17","author":"D Malin","year":"2011","unstructured":"Malin D, Chen F, Schiller C, Koblinski J, Cryns VL (2011) Enhanced metastasis suppression by targeting TRAIL receptor 2 in a murine model of triple-negative breast cancer. Clin Cancer Res 17:5005\u20135015","journal-title":"Clin Cancer Res"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cmet.2015.08.024","volume":"22","author":"SJ Mentch","year":"2015","unstructured":"Mentch SJ, Mehrmohamadi M, Huang L, Liu X, Gupta D, Mattocks D et al (2015) Histone methylation dynamics and gene regulation occur through the sensing of one-carbon metabolism. Cell Metab 22:861\u2013873","journal-title":"Cell Metab"},{"key":"6_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1158\/1078-0432.CCR-13-1255","volume":"20","author":"D Malin","year":"2014","unstructured":"Malin D, Strekalova E, Petrovic V, Deal AM, Al Ahmad A, Adamo B et al (2014) \u03b1B-crystallin: a novel regulator of breast cancer metastasis to the brain. Clin Cancer Res 20:56\u201367","journal-title":"Clin Cancer Res"},{"key":"6_CR22","doi-asserted-by":"publisher","first-page":"17104","DOI":"10.1073\/pnas.1418637111","volume":"111","author":"TL Halo","year":"2014","unstructured":"Halo TL, McMahon KM, Angeloni NL, Xu Y, Wang W, Chinen AB et al (2014) NanoFlares for the detection, isolation, and culture of live tumor cells from human blood. Proc Natl Acad Sci U S A 111:17104\u201317109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"6_CR23","first-page":"901","volume":"13","author":"X Fu","year":"1993","unstructured":"Fu X, Le P, Hoffman RM (1993) A metastatic orthotopic-transplant nude-mouse model of human patient breast cancer. Anticancer Res 13(4):901\u2013904","journal-title":"Anticancer Res"},{"issue":"4","key":"6_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1023\/A:1015510207431","volume":"19","author":"X Li","year":"2002","unstructured":"Li X, Wang J, Yang M, Baranov E, Jinag P, Sun F, Moussa AR, Hoffman RM (2002) Optically imageable metastatic model of human breast cancer. Clin Exp Metastasis 19(4):347\u2013350","journal-title":"Clin Exp Metastasis"},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"e0163521","DOI":"10.1371\/journal.pone.0163521","volume":"11","author":"M Puchalapalli","year":"2016","unstructured":"Puchalapalli M, Zeng X, Mu L, Anderson A, Hix Glickman L, Zhang M et al (2016) NSG mice provide a better spontaneous model of breast cancer metastasis than athymic (nude) mice. PLoS One 11:e0163521","journal-title":"PLoS One"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"9308","DOI":"10.1158\/0008-5472.CAN-06-1769","volume":"66","author":"JC Harrell","year":"2006","unstructured":"Harrell JC, Dye WW, Allred DC, Jedlicka P, Spoelstra NS, Sartorius CA et al (2006) Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes. Cancer Res 66:9308\u20139315","journal-title":"Cancer Res"}],"container-title":["Methods in Molecular Biology","Methionine Dependence of Cancer and Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-8796-2_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T05:09:36Z","timestamp":1558069776000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-8796-2_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493987955","9781493987962"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-8796-2_6","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"7 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}